Securities code: 300981 securities abbreviation: Zhonghong Pulin Medical Products Co.Ltd(300981) Announcement No.: 2022-004 Zhonghong Pulin Medical Products Co.Ltd(300981)
Announcement on the resolution of the sixth meeting of the third board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings held
Zhonghong Pulin Medical Products Co.Ltd(300981) the sixth meeting of the third board of supervisors was held by means of communication on February 23, 2022. On February 16, 2022, the company sent a meeting notice to all supervisors by telephone and e-mail. The meeting was presided over by Mr. Xu Zhongxian, chairman of the board of supervisors. The convening and holding of the meeting shall comply with the provisions of relevant laws, regulations and the articles of association.
2、 Deliberations of the meeting
1. Deliberated and passed the proposal on using its own idle funds to invest in low-risk financial products;
The company plans to use its own idle funds of no more than RMB 4 billion to purchase financial products with high safety, good liquidity and controllable risk under the condition of ensuring the capital demand of normal production and operation, which will be effective within one year from the date of deliberation and approval by the general meeting of shareholders. The company uses its own idle funds to invest in low-risk financial products, which is conducive to improving the use efficiency of its own funds, obtaining certain investment income and seeking better investment return for the company and shareholders. The use of its own idle funds to invest in low-risk financial products will not affect the company’s normal capital turnover and the development of normal production and operation activities, there is no damage to the interests of the company and shareholders, and the approval procedures comply with the relevant provisions of laws and regulations and the articles of association. See the website of cninfo for details（ http://www.cn.info.com.cn. ）Announcement on using self owned idle funds to invest in low-risk financial products (Announcement No.: 2022-005).
The voting result is: 3 in favor, 0 against and 0 abstention.
This proposal needs to be submitted to the general meeting of shareholders of the company for deliberation and approval.
2. Deliberated and passed the proposal on cash management using temporarily idle over raised funds and their interests; The company plans to conduct cash management on the temporarily idle over raised funds and their interests before determining the investment plan without affecting the construction of the investment projects invested by the raised funds and the normal operation of the company, so as to increase the income of the company; Investment products for cash management include but are not limited to financial products with high security and good liquidity, such as structured deposits, time deposits, large certificates of deposit and reverse repurchase of government bonds. The amount of idle over raised funds and their interest shall not exceed 1.45 billion yuan, the term of a single financial product shall not exceed 12 months, and the funds can be used circularly and continuously, Valid within 12 months from the date of deliberation and approval by the general meeting of shareholders; The board of directors requests the general meeting of shareholders to authorize the chairman, general manager or their authorized personnel to sign relevant contract documents, and the specific matters shall be implemented by the Finance Department of the company. The company’s cash management with idle over raised funds and their interests is carried out on the premise of ensuring the progress of the company’s investment projects with raised funds and ensuring the safety of funds, which will not affect the development and normal production and operation of the company’s investment projects with raised funds. We agree with the proposal. See the website of cninfo for details（ http://www.cn.info.com.cn. ）Announcement on cash management using temporarily idle over raised funds and their interests (Announcement No.: 2022-006).
The voting result is: 3 in favor, 0 against and 0 abstention.
This proposal needs to be submitted to the general meeting of shareholders of the company for deliberation and approval.
3. The proposal on the company and its subsidiaries applying to the bank for comprehensive credit line in 2022 and the company providing guarantee for its subsidiaries applying for comprehensive credit line was deliberated and adopted.
In 2022, the company and its subsidiaries intend to apply to relevant banks for a comprehensive credit line of no more than 4 billion yuan in total, which shall be subject to the credit line actually approved by each bank. Among them, the total credit line applied to the above financial institutions by means of self owned assets mortgage and pledge shall not exceed 1 billion yuan, and each mortgage and pledge subject can be used within the scope of the total mortgage and pledge line; Among them, in 2022, the company’s wholly-owned subsidiary Jiangxi zhonghongprin Medical Products Co., Ltd. (hereinafter referred to as “Jiangxi Zhonghong”) plans to apply for some comprehensive credit lines from relevant banks, and the company will provide a guarantee with a total amount of no more than 1 billion yuan to relevant banks.
In order to facilitate the implementation of the above application for credit and guarantee from the bank, the general meeting of shareholders is requested to authorize the company and Jiangxi Zhonghong to determine the specific credit and guarantee matters such as the credit subject, the mortgage and pledge subject, the selection of financial institutions and the specific variety, amount and term used in the application for credit line within the above credit line and guarantee line, The legal representative of the company or its designated agent and the legal representative of Jiangxi Zhonghong are authorized to sign relevant legal documents within the limit and handle relevant matters on behalf of the company. The signing period is from the date of deliberation and approval by the general meeting of shareholders to December 31, 2022.
See the website of cninfo for details（ http://www.cn.info.com.cn. ）Announcement on the company and its subsidiaries applying to the bank for comprehensive credit line in 2022 and the company providing guarantee for its subsidiaries applying for comprehensive credit line (Announcement No.: 2022-007).
The voting result is: 3 in favor, 0 against and 0 abstention.
This proposal needs to be submitted to the general meeting of shareholders for deliberation and approved by more than two-thirds of the voting rights held by the shareholders attending the meeting.
3、 Documents for future reference
1. Resolutions of the sixth meeting of the third board of supervisors;
It is hereby announced.
Zhonghong Pulin Medical Products Co.Ltd(300981) board of supervisors February 23, 2002
